Pfizer Inc. (PFE)
Pfizer taps Vanguard veteran for board amid fight with Starboard
Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as it faces pressure from activist hedge fund Starboard Value.
Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock?
This investor's campaign is stoking some undesirable corporate intrigue.
Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note
In the closing of the recent trading day, Pfizer (PFE) stood at $29.08, denoting a -0.27% change from the preceding trading day.
Pfizer Secures FDA Approval for Hemophilia Drug Hympavzi
Following the FDA approval, PFE's Hympavzi becomes the first hemophilia medicine approved in the United States to be administered via a pre-filled, auto-injector pen.
Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly?
These two stocks will appeal to very different types of investors at the moment.
Pfizer wins FDA approval for hemophilia B drug that will be first once-weekly treatment
The new drug would allow patients to produce the needed clotting protein for an extended period, reducing the need for constant intravenous infusions or injections, which are painful as well as inconvenient.
US FDA approves Pfizer's drug for rare bleeding disorder
The U.S. Food and Drug Administration approved Pfizer's once-a-week injection for the two main types of a rare bleeding disorder called hemophilia, the company said on Friday.
An Activist Investor Just Bought $1 Billion Worth of Pfizer. Here's What It Means for the Stock
There may be changes coming to this company, if the activists get their way.
Why Pfizer Stock Tumbled by Nearly 3% on Thursday
The company's latest institutional shareholder has made some troubling allegations against it.
Pfizer battles activist fund Starboard, which has a $1 billion stake in company
CNBC Angelica Peebles joins 'Power Lunch' to report on Pfizer's activist battle.
Ex-Pfizer Execs Backed Its Leadership. An Activist Investor Says They Were 'Threatened'
Pfizer (PFE) shares lost ground Thursday after two former executives released a statement supporting the company's current management after activist investor Starboard Value this week took a $1 billion stake in the struggling drug maker and moved to make changes.
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?
Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
